Phase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancer

Leary, A.Estevez-Garcia, P.Sabatier, R.Farinas-Madrid, L.Perez-Fidalgo, J. A.Romeo, M.Barretina Ginesta, M. P.Gil-Martin, M.Garralda, E.Rodon, J.Lizcano, J. M.Munoz Guardiola, P.Perez-Montoyo, H.Yeste-Velasco, M.Cortal, M.Domenech, C.Alfon, J.Ray-Coquard, I. L.Oaknin, A.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/27213enPhase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancerconference outputopen access10.1016/j.annonc.2020.08.10031569-8041http://www.annalsofoncology.org/article/S0923753420409998/pdf573469101152